284 related articles for article (PubMed ID: 17611791)
1. Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy.
Finucane FM; O'Connell J; Kinsley BT
Ir J Med Sci; 2008 Mar; 177(1):69-71. PubMed ID: 17611791
[TBL] [Abstract][Full Text] [Related]
2. Propylthiouracil-induced agranulocytosis in the third trimester of pregnancy.
Murji A; Sobel ML; Feig DS; Sermer M
Obstet Gynecol; 2010 Aug; 116 Suppl 2():485-487. PubMed ID: 20664427
[TBL] [Abstract][Full Text] [Related]
3. Management of a pregnant patient with Graves' disease complicated by propylthiouracil induced agranulocytosis.
Cho YY; Shon HS; Yoon HD
Korean J Intern Med; 2005 Dec; 20(4):335-8. PubMed ID: 16491833
[TBL] [Abstract][Full Text] [Related]
4. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
[TBL] [Abstract][Full Text] [Related]
5. Management of a pregnant patient with Graves' disease complicated by thionamide-induced neutropenia in the first trimester.
Davison S; Lennard TW; Davison J; Kendall-Taylor P; Perros P
Clin Endocrinol (Oxf); 2001 Apr; 54(4):559-61. PubMed ID: 11318795
[TBL] [Abstract][Full Text] [Related]
6. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
[TBL] [Abstract][Full Text] [Related]
7. A successful pregnancy and delivery case of Graves' disease with myeloperoxidase antineutrophil cytoplasmic antibody induced by propylthiouracil.
Yamashita Y; Yamane K; Fujikawa R; Okubo M; Kohno N
Endocr J; 2002 Oct; 49(5):555-9. PubMed ID: 12507274
[TBL] [Abstract][Full Text] [Related]
8. Antithyroid drugs.
Cooper DS
N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981
[No Abstract] [Full Text] [Related]
9. Propylthiouracil-induced agranulocytosis as a rare complication of antithyroid drugs in a patient with Graves' disease.
Rabelo PN; Rabelo PN; Paula AF; Conceição SAD; Viggiano DPPO; Antunes DE; Jatene EM; Paula SLFM; Dias ML; Reis MAL
Rev Assoc Med Bras (1992); 2019 Jul; 65(6):755-760. PubMed ID: 31340298
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of preoperative plasmapheresis in a pregnancy complicated by hyperthyroidism and anti-thyroid drug-associated angioedema.
Bilir BE; Atile NS; Kirkizlar O; Kömürcü Y; Akpinar S; Sezer A; Demir M; Hekimoğlu S
Gynecol Endocrinol; 2013 May; 29(5):508-10. PubMed ID: 23383744
[TBL] [Abstract][Full Text] [Related]
11. Agranulocytosis associated with anti-thyroid drug in patients with Graves' thyrotoxicosis--report of 11 cases.
Li KL; Huang HS; Wang PW; Lin JD; Juang JH; Liu RT; Huang BY; Huang MJ
Changgeng Yi Xue Za Zhi; 1991 Sep; 14(3):168-73. PubMed ID: 1718579
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.
Poomthavorn P; Mahachoklertwattana P; Tapaneya-Olarn W; Chuansumrit A; Chunharas A
J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1295-301. PubMed ID: 12549809
[TBL] [Abstract][Full Text] [Related]
13. [Antineutrophil cytoplasmic antibody (Anca)-associated autoimmune disease induced by propylthiouracil].
Pietszkowski NC; Carvalho GA; Souza HN; Werka CR; Borazo LA; Graf H; Carvalho Md
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):136-41. PubMed ID: 17435868
[TBL] [Abstract][Full Text] [Related]
14. Propylthiouracil-induced sensorineural hearing loss associated with antineutrophil cytoplasmic antibodies.
Thamprajamchit S; Jariengprasert C; Rajatanavin R
Endocr Pract; 2004; 10(5):432-7. PubMed ID: 15760792
[TBL] [Abstract][Full Text] [Related]
15. Recurrent episodes of arthritis in a hyperthyroid patient.
Tan F; Nam TQ; Lee KO; Cheah WK; Mukherjee JJ
Singapore Med J; 2006 Feb; 47(2):163-5. PubMed ID: 16435062
[TBL] [Abstract][Full Text] [Related]
16. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy.
Bowman P; Osborne NJ; Sturley R; Vaidya B
QJM; 2012 Feb; 105(2):189-93. PubMed ID: 21258054
[TBL] [Abstract][Full Text] [Related]
17. [Plasmapheresis before thyroidectomy in a patient with thyrotoxicosis and hepatotoxicity by propylthiouracil: case report].
Almeida RF; Comarella AP; Silveira MB; Silva AR; Ferri Casini A
Arq Bras Endocrinol Metabol; 2013 Jun; 57(4):322-6. PubMed ID: 23828438
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and outcomes in patient with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment in Siriraj Hospital.
Visavachaipan N; Ong-Ajyooth L; Chanchairujuira T; Parichatikanond P; Choensuchon B
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S139-46. PubMed ID: 20364568
[TBL] [Abstract][Full Text] [Related]
19. [Antineutrophil cytoplasmic antibody associated vasculitis: an uncommon side effect of propylthiouracil].
Pasquet F; Pavic M; Mounier C; Karkowski L; Colle B
Rev Med Interne; 2009 Oct; 30(10):882-5. PubMed ID: 19740576
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
Huang CN; Hsu TC; Chou HH; Tsay GJ
J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
